Ligand validation:3RY2

BTN: BIOTIN

BTN is a Ligand Of Interest in 3RY2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RY2_BTN_B_5001	97%	37%	0.069	0.986	1.21	1.25	1	1	0	0	100%	1
3RY2_BTN_A_5001	96%	33%	0.073	0.982	1.22	1.42	2	2	0	0	100%	1
3T6F_BTN_A_5100	100%	9%	0.044	0.992	2.02	2.37	4	7	0	0	100%	0.8
6AUL_BTN_A_201	99%	13%	0.051	0.985	1.6	2.33	6	5	0	0	100%	1
2RTF_BTN_D_301	99%	16%	0.044	0.975	1.21	2.44	3	6	0	0	100%	1
2IZI_BTN_A_300	99%	14%	0.05	0.981	1.04	2.8	2	8	0	0	100%	1
3WYP_BTN_D_1001	99%	10%	0.064	0.994	1.65	2.61	3	6	0	0	100%	1
3WYQ_BTN_B_1001	100%	25%	0.045	0.993	1.69	1.37	4	3	0	0	100%	1
3WZN_BTN_A_1001	100%	5%	0.044	0.989	1.86	3.39	3	12	0	0	100%	1
1HXD_BTN_A_500	100%	41%	0.051	0.992	0.66	1.59	-	3	1	0	100%	1
3T2W_BTN_A_600	99%	11%	0.048	0.986	2.57	1.59	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.